Plus, news about Arvinas, Alnylam, Sihuan Pharmaceutical, Neurizon Therapeutics, Nordicus Partners, and Arcutis:
🫀 NanoPhoria raises $98M Series A: The cash will fund early clinical development of the Milan-based company’s heart failure candidate, known as ...
↧